Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Stock Information

NASDAQLPCN
$2.34
NASDAQLPCN
Open
$2.14
Change
$0.20 (9.35%)
Day's Range
$2.02 - $2.35
52-Week Range
$1.04 - $2.64
Volume
356.3K
Market Cap
$58.1M